Non-canonical PI3K-Cdc42-Pak-Mek-Erk Signaling Promotes Immune-Complex-Induced Apoptosis in Human Neutrophils

被引:30
作者
Chu, Julia Y. [1 ]
Dransfield, Ian [1 ]
Rossi, Adriano G. [1 ]
Vermeren, Sonja [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland
基金
英国医学研究理事会;
关键词
NUCLEOTIDE EXCHANGE FACTOR; CROSS-CASCADE ACTIVATION; PROTEIN-KINASE B; BONE-MARROW; GROWTH-FACTOR; MECHANISMS; ERK; INHIBITORS; PATHWAY; MEK1;
D O I
10.1016/j.celrep.2016.09.006
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Neutrophils are peripheral blood leukocytes that represent the first line of immune cell defense against bacterial and fungal infections but are also crucial players in the generation of the inflammatory response. Many neutrophil cell surface receptors regulate important cellular processes via activation of agonist-activated PI3Ks. We show here that activation of human neutrophils with insoluble immune complexes drives a previously uncharacterized, PI3K-dependent, non-canonical, pro-apoptotic signaling pathway, Fc gamma R-PI3K beta/delta-Cdc42-Pak-Mek-Erk. This is a rare demonstration of Ras/Raf-independent activation of Erk and of PI3K-mediated activation of Cdc42. In addition, comparative analysis of immune-complex- and fMLF-induced signaling uncovers key differences in pathways used by human and murine neutrophils. The non-canonical pathway we identify in this study may be important for the resolution of inflammation in chronic inflammatory diseases that rely on immune-complex-driven neutrophil activation.
引用
收藏
页码:374 / 386
页数:13
相关论文
共 60 条
[1]
Discovery of a Highly Potent and Selective MEK Inhibitor: GSK1120212 (JTP-74057 DMSO Solvate) [J].
Abe, Hiroyuki ;
Kikuchi, Shinichi ;
Hayakawa, Kazuhide ;
Iida, Tetsuya ;
Nagahashi, Noboru ;
Maeda, Katsuya ;
Sakamoto, Johei ;
Matsumoto, Noriaki ;
Miura, Tomoya ;
Matsumura, Koji ;
Seki, Noriyoshi ;
Inaba, Takashi ;
Kawasaki, Hisashi ;
Yamaguchi, Takayuki ;
Kakefuda, Reina ;
Nanayama, Toyomichi ;
Kurachi, Hironori ;
Hori, Yoshikazu ;
Yoshida, Takayuki ;
Kakegawa, Junya ;
Watanabe, Yoshihiro ;
Gilmartin, Aidan G. ;
Richter, Mark C. ;
Moss, Katherine G. ;
Laquerre, Sylvie G. .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (04) :320-324
[2]
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[3]
Spatio-temporal regulation of Rac1 and Cdc42 activity during nerve growth factor-induced neurite outgrowth in PC12 cells [J].
Aoki, K ;
Nakamura, T ;
Matsuda, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (01) :713-719
[4]
Bergamini G, 2012, NAT CHEM BIOL, V8, P576, DOI [10.1038/nchembio.957, 10.1038/NCHEMBIO.957]
[5]
Biology of the p21-activated kinases [J].
Bokoch, GM .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :743-781
[6]
Mouse bone marrow contains large numbers of functionally competent neutrophils [J].
Boxio, R ;
Bossenmeyer-Pourié, C ;
Steinckwich, N ;
Dournon, C ;
Nüsse, O .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (04) :604-611
[7]
Synergy in activating class I PI3Ks [J].
Burke, John E. ;
Williams, Roger L. .
TRENDS IN BIOCHEMICAL SCIENCES, 2015, 40 (02) :88-100
[8]
ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence [J].
Cagnol, Sebastien ;
Chambard, Jean-Claude .
FEBS JOURNAL, 2010, 277 (01) :2-21
[9]
MEK1 and MEK2 inhibitors and cancer therapy: the long and winding road [J].
Caunt, Christopher J. ;
Sale, Matthew J. ;
Smith, Paul D. ;
Cook, Simon J. .
NATURE REVIEWS CANCER, 2015, 15 (10) :577-592
[10]
The mechanism of PAK activation - Autophosphorylation events in both regulatory and kinase domains control activity [J].
Chong, C ;
Tan, L ;
Lim, L ;
Manser, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17347-17353